Sinocare Can't Scrap Abbott's Glucose Monitor Ban At UPC

By Alex Baldwin ( April 2, 2026, 5:58 PM BST) -- U.S. pharmaceutical company Abbott Laboratories has convinced appellate judges at the Unified Patent Court to uphold its preliminary injunction against Sinocare and its European distributor, marking the latest in Abbott's crackdown on rival glucose monitor makers....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies